Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 525.5	$ 415.8
Accounts receivable, less allowance for credit losses	1,480.7	1,442.4
Inventories	2,235.3	2,385.2
Prepaid expenses and other current assets	430.1	366.1
Total Current Assets	4,671.5	4,609.5
Property, plant and equipment, net	2,048.8	2,060.4
Goodwill	8,951.1	8,818.5
Intangible assets, net	4,598.4	4,856.4
Other assets	1,095.5	1,152.1
Total Assets	21,365.3	21,496.9
Current Liabilities:
Accounts payable	194.6	410.6
Other current liabilities	1,393.3	1,546.9
Current portion of long-term debt	863.0	900.0
Total Current Liabilities	2,450.9	2,857.4
Deferred income taxes, net	352.5	357.6
Other long-term liabilities	744.1	925.8
Long-term debt	5,341.6	4,867.9
Total Liabilities	8,889.1	9,008.7
Commitments and Contingencies (Note 21)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 317.5 million (316.2 million in 2023) issued	3.2	3.2
Paid-in capital	10,038.1	9,846.1
Retained earnings	11,095.3	10,384.5
Accumulated other comprehensive loss	(262.8)	(191.0)
Treasury stock, 118.4 million shares (110.6 million shares in 2023)	(8,405.7)	(7,562.3)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,468.1	12,480.5
Noncontrolling interest	8.1	7.7
Total Stockholders' Equity	12,476.2	12,488.1
Total Liabilities and Stockholders' Equity	$ 21,365.3	$ 21,496.9